According to Oncomine (http://www.oncomine.org)16, HOXA5 is highly expressed in AML, gastrointestinal stromal tumors, and glioblastomas, whereas it is weakly expressed in breast, colon, lung, and ovarian cancers. Here, HOXA5 is linked to ovarian cancer.